Routine Blood Tests
- Day 3 FSH and Estradiol
- Thyroid stimulating hormone (TSH)
- Prolactin
- VZV IgG (to test chicken pox exposure)
- Rubella Titre
- Complete blood count
- Blood Type
- HIV, hepatitis B, hepatitis C, syphilis testing
Follicle Stimulation Hormone (FSH)
The Follicle Stimulation Hormone is made by the pituitary to recruit an egg follicle to develop and mature each cycle. A day 3 test gives us insight into your ovarian reserve or your egg supply. This helps us predict how well you might respond to fertility medications or assisted reproductive therapies (ART) like superovulation or IVF.
Anti mullerian Hormone (AMH)
Anti-Mullerian Hormone (AMH) is a blood test that measures the level of a hormone produced by the ovaries. This test can provide valuable information about your ovarian reserve or the number of eggs that you have remaining in your ovaries.
Knowing your AMH level can help your doctor determine your chances of getting pregnant and can also guide the selection of fertility treatment options. If your AMH level is low, it may indicate that you have a low ovarian reserve and that your chances of getting pregnant with your own eggs may be lower. However, it’s important to remember that AMH is just one piece of information that your doctor will use to assess your fertility.
In general, a higher AMH level indicates that a woman has a greater number of eggs and may respond better to fertility treatments. If your AMH level is low, your doctor may recommend more aggressive fertility treatments, such as in vitro fertilization (IVF) to increase your chances of getting pregnant.
It’s important to note that AMH is just one of several factors that influence fertility, and it doesn’t provide a complete picture of a woman’s fertility potential. This valuable test is not covered by MSP. The labs charge approximately $70-90.
What is the difference between AMH and FSH?
Anti-Mullerian Hormone (AMH) and Follicle Stimulating Hormone (FSH) are two different hormone tests that can be used to assess a woman’s ovarian reserve, or the number of eggs remaining in her ovaries. While both tests are useful, AMH is generally considered to be a more accurate marker of ovarian reserve than FSH for several reasons.
First, AMH is produced by the follicles in a woman’s ovaries and is a more direct marker of ovarian reserve than FSH, which is produced by the pituitary gland in the brain and is influenced by many other factors in the body.
Second, AMH levels remain relatively stable throughout a woman’s menstrual cycle, whereas FSH levels fluctuate widely throughout the cycle. This means that AMH can be tested at any time during the menstrual cycle, while FSH levels are typically measured on the third day of the cycle.
Finally, AMH levels are less affected by external factors such as stress or illness, which can impact FSH levels and make the results less accurate.
Overall, while both tests can be useful in assessing ovarian reserve, AMH is considered to be a more reliable and accurate predictor of a woman’s fertility potential. However, it’s important to note that no single test can provide a complete picture of a woman’s fertility, and your doctor will take into account multiple factors when evaluating your fertility potential.
It’s important to note that AMH is just one of several factors that influence fertility, and it doesn’t provide a complete picture of a woman’s fertility potential. This valuable test is not covered by MSP. The labs charge approximately $70-90.
Thyroid stimulating hormone (TSH)
Abnormal thyroid levels are common in women of childbearing age and can cause irregular menstrual period, infertility, and miscarriage. Thyroid problems are usually very treatable.
Prolactin
Elevated prolactin levels (hyperprolactinemia) in women that are not nursing can interfere with the normal production of estrogen and progesterone. This can change or stop ovulation and cause infertility.